Lene H. Jensen
Frederiksberg, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Colchicine twice a day for hand osteoarthritis (COLOR): a double-blind, randomised, placebo-controlled trial.
Journal: The Lancet. Rheumatology
Published: December 21, 2022
Sources, distribution and fate of microfibres on the Great Barrier Reef, Australia.
Journal: Scientific reports
Published: January 14, 2019
The fate of microplastics during uptake and depuration phases in a blue mussel exposure system.
Journal: Environmental toxicology and chemistry
Published: June 04, 2018
Effect of once-weekly semaglutide on the counterregulatory response to hypoglycaemia in people with type 2 diabetes: A randomized, placebo-controlled, double-blind, crossover trial.
Journal: Diabetes, obesity & metabolism
Published: March 05, 2018
A Randomized Trial Investigating the Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Semaglutide Once-Weekly in Healthy Male Japanese and Caucasian Subjects.
Journal: Advances in therapy
Published: January 10, 2018
Pharmacokinetics and tolerability of semaglutide in people with hepatic impairment.
Journal: Diabetes, obesity & metabolism
Published: July 10, 2017
Absorption, metabolism and excretion of the GLP-1 analogue semaglutide in humans and nonclinical species.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: December 01, 2016
Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes Mellitus.
Journal: Clinical pharmacokinetics
Published: June 11, 2016
Semaglutide, a once-weekly human GLP-1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel.
Journal: Journal of clinical pharmacology
Published: September 11, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026